Drugs / GENEVAX® IL-12 DNA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03663998 Comparator | Aug 2015 → May 2017 | HIV infectious disease | Imperial College London | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GENEVAX IL-12 DNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03663998 ↗ |